Clinical Trial Update: Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

View source ↗

Summary

The document notes that fenfluramine (Fintepla) has been approved for marketing for the treatment of Dravet Syndrome, including its use under an expanded access…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fintepla (Fenfluramine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Dravet Syndrome | Status: APPROVED_FOR_MARKETING